share_log

JMP Securities Reiterates Market Outperform on Cormedix, Maintains $19 Price Target

JMP Securities Reiterates Market Outperform on Cormedix, Maintains $19 Price Target

JMP Securities重申Cormedix的市場跑贏大盤,維持19美元的目標股價
Benzinga ·  2023/11/15 12:57

JMP Securities analyst Jason Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $19 price target.

JMP Securities分析師傑森·巴特勒重申Cormedix(納斯達克股票代碼:CRMD)的市場表現優於大盤,並維持19美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論